Search results
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 6 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 3 days agoThe company, which developed and sells the Spikevax COVID-19 vaccine, saw its share price balloon by almost 13% thanks to an encouraging ...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 3 days agoFinancial and Operational Highlights The significant revenue drop primarily stemmed from decreased...
New mRNA cancer vaccine triggers immune system to fight aggressive brain tumour
PA Media: Science via Yahoo News· 4 days agoAlthough it is too early to assess the clinical effects of the vaccine, the patients in the new...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 3 days agoThey are also testing the cancer vaccine in patients with lung cancer. So, is Moderna stock now a...
Top Stock Movers Now: Moderna, Wayfair, Peloton Interactive, and More
Investopedia· 3 days agoThe Dow, S&P 500, and Nasdaq all rose. Moderna (MRNA) shares advanced after the vaccine maker...
The CDC Took Out 148 Pages of Essential Information
Mercola· 2 days agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of ...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoThe firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States ...
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
Guru Focus· 1 day agoTotal revenue plummeted by 91% from $1.862 billion in Q1 2023 to $167 million in Q1 2024, while net income turned to a loss of $1.175 billion compared to a gain of $79 million in the prior year ...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 3 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula ...
